Study Details

Back
Study ID 0113-CL-1003
Study Title An Open Phase 2 Trial to Evaluate Safety of a Therapeutic Vaccine, ASP0113, in Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Clinicaltrials.gov Identifier NCT01903928
Compound Name ASP0113
Medical Indication or Disease Prevention of CMV infection
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 20-Jun-2013
Study Completion Date 19-Jan-2015
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS